Amarin Corp Plc (AMRN)

[Whalatane]

RMB as a follow up re acquisitions . Acquisitions happen for several different reasons.
Some Co's may have excellent P 2 trial results but are unable to fund a final pivotal trial(s ) needed for FDA approval or simply receive an offer to good to refuse from a larger Co. ...recent sales of Co's developing drugs for IgaN ( kidney disease ) for instance
Other Co's like UNCY are not set up to launch the sales of their drug and will almost certainly look for a buyer if their final trial succeeds....same with TLPH .
AMRN is an economies of scale situation ...as presented in Denners sales pitch .
NVS has the economies of scale
Kiwi